Publisher's Synopsis
Cholecsytokinin is an abundant brain peptide implicated in Parkinson's disease, amongst many others and rapid pharmaceutical advancement is being made in its therapeutic role.;This volume reflects the views of a group of international scientists who met at Cambridge to discuss current developments in the field of cholecystokinin research. Topics discussed include the organization of CCK-containing systems, the mechanisms of action with neurochemical studies on receptor mechanisms and electrophysiological techniques. The section covering physiological function and pharmacological manipulation is divided into reviews of antagonists and receptor classification, as well as reviews of peripheral and central functions.
